Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
The efficacy of psychedelic-assisted therapies for mental disorders has been attributed to the lasting change from experiential avoidance to acceptance that these treatments appear to facilitate. This article presents a conceptual model that specifies the psychological mechanisms underlying such change, and that shows substantial parallels between psychedelic therapy and cognitive behavioral therapy: We propose that under the carefully controlled conditions of psychedelic therapy as applied in contemporary clinical research, psychedelic-induced belief relaxation can increase motivation for acceptance via operant conditioning, thus engendering episodes of relatively avoidance-free exposure to greatly intensified private events. Under these unique learning conditions, relaxed avoidance-related beliefs can be exposed to corrective experiences and become revised accordingly, which may explain to long-term increases in acceptance and corresponding reductions in psychopathology. Open research questions and implications for clinical practice are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The free-energy principle: a unified brain theory?
Friston, K. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2787 · Cited by 8,120 · cited 1×
“The theory's neurobiological and information theoretical details are beyond the scope of this article, but understanding belief relaxation sufficiently to follow our argument requires a basic concept of predictive processing, arguably the leading unified account of brain and mind function (62, 63).”
BackgroundAcceptance and commitment therapy: model, processes and outcomes
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., & Lillis, J. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.06.006 · Cited by 6,587 · cited 1×
“Verbal interventions aimed at facilitating the revision of such beliefs can focus on changing either their content or functional impact on behavior, and may involve disputation via Socratic dialogue (30), metaphors (31), decentering or psychological distancing (32), defusion exercises (31), etc.”
BackgroundWhatever next? Predictive brains, situated agents, and the future of cognitive science
Clark, A. (2013) · Behavioral and Brain Sciences · doi:10.1017/s0140525x12000477 · Cited by 5,924 · cited 1×
“The theory's neurobiological and information theoretical details are beyond the scope of this article, but understanding belief relaxation sufficiently to follow our argument requires a basic concept of predictive processing, arguably the leading unified account of brain and mind function (62, 63).”
BackgroundMindfulness training as a clinical intervention: a conceptual and empirical review
Baer, R. A. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.bpg015 · Cited by 4,577
Mindfulness training as a clinical intervention: A conceptual and empirical review.
Baer, R. A. (2003) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy/bpg015 · Cited by 4,576
Shapiro, S. L., Carlson, L. E., Astin, J. A., & Freedman, B. (2006) · Journal of Clinical Psychology · doi:10.1002/jclp.20237 · Cited by 4,002 · cited 1×
“Acceptancebased CBTs commonly pursue exposure through mindfulnessbased exercises, which resemble classical exposure treatment of anxiety disorders in that a stimulus (in this case private events such as emotions, thoughts, memories, or body sensations) is openly attended to while desisting from avoidant responses (25,…”
BackgroundHayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., & Strosahl, K. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.6.1152 · Cited by 3,595
The Neuroscience of Mindfulness Meditation
Tang, Y.-Y., Hölzel, B. K., & Posner, M. I. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn3916 · Cited by 2,889
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422 · cited 1×
“panic attacks, which is assumed to be driven by catastrophic misinterpretation of (and associated avoidant responses to) body sensations (68).”
BackgroundMaximizing exposure therapy: An inhibitory learning approach
Craske, M. G., Treanor, M., Conway, C. C., Zbozinek, T., & Vervliet, B. (2014) · Behaviour Research and Therapy · doi:10.1016/j.brat.2014.04.006 · Cited by 2,339 · cited 2×
“It is well established that extinction learning in exposure treatments is most effective when negative expectancies regarding the outcomes of exposure are maximally violated (33).”
BackgroundGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“Blissful ego-dissolution and related phenomena such as “oceanic boundlessness” and “mystical-type experiences” have been shown to predict not only long-term increases in well-being (80, 85) and trait openness in non-clinical samples (59, 60, 89) but also positive clinical outcomes (5, 7, 11, 46).”
BackgroundAddiction motivation reformulated: an affective processing model of negative reinforcement
Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004) · Psychological Review · doi:10.1037/0033-295x.111.1.33 · Cited by 2,162 · cited 2×
“Beyond CBT, most other schools of psychotherapy also recognize the role of experiential avoidance or related concepts in human suffering (21).”
BackgroundObsessional-compulsive problems: A cognitive-behavioural analysis
Salkovskis, P. M. (1985) · Behaviour Research and Therapy · doi:10.1016/0005-7967(85)90105-6 · Cited by 1,842 · cited 1×
“In obsessive-compulsive disorder, washing rituals may neutralize worries about contamination (22), etc.”
BackgroundRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1×
“In recent years, several early-phase clinical trials have provided evidence that classic serotonergic psychedelics—in most cases psilocybin, but also lysergic acid diethylamide (LSD) and the dimethyltryptamine (DMT)-containing brew ayahuasca—may occasion substantial and often sustained symptom reductions in patients t…”
BackgroundPsilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914 · cited 1×
“In recent years, several early-phase clinical trials have provided evidence that classic serotonergic psychedelics—in most cases psilocybin, but also lysergic acid diethylamide (LSD) and the dimethyltryptamine (DMT)-containing brew ayahuasca—may occasion substantial and often sustained symptom reductions in patients t…”
BackgroundMacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Cognitive Behavioural Processes across Psychological Disorders (DRAFT)
Harvey, A., Watkins, E., Mansell, W., & Shafran, R. (2004) · doi:10.1093/med:psych/9780198528883.001.0001 · Cited by 869
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852
Experiential avoidance as a functional dimensional approach to psychopathology: An empirical review
Chawla, N., & Ostafin, B. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20400 · Cited by 805 · cited 1×
“) despite harmful long-term consequences—is considered a central factor underlying the development and maintenance of a wide range of psychopathologies (23, 24).”
BackgroundSafety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · cited 1×
“In recent years, several early-phase clinical trials have provided evidence that classic serotonergic psychedelics—in most cases psilocybin, but also lysergic acid diethylamide (LSD) and the dimethyltryptamine (DMT)-containing brew ayahuasca—may occasion substantial and often sustained symptom reductions in patients t…”
BackgroundGasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · cited 3×
“Examining the Role of Ego-Dissolution Experiences To date, most of the evidence supporting the EP model's core assumption that acute responses to psychedelics predict longerterm outcomes (44) relates to acute ego-dissolution, i.”
MethodResultInfluentialLong-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · cited 2×
“, a heightened susceptibility toward ongoing processes in the internal and external context [or “set” and “setting”; see (64, 65)].”
BackgroundWells, A., & Davies, M. I. (1994) · Behaviour Research and Therapy · doi:10.1016/0005-7967(94)90168-6 · Cited by 640 · cited 1×
“, (82)], thought suppression (83), and beliefs about the unacceptability of emotions (84).”
BackgroundWatts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · cited 9×
“Psychedelic therapy thus appears to promote lasting change from experiential avoidance to acceptance (13).”
BackgroundResultInfluentialGriffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., Jesse, R., MacLean, K. A., Barrett, F. S., Cosimano, M. P., & Klinedinst, M. A. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117731279 · Cited by 520 · cited 2×
“Blissful ego-dissolution and related phenomena such as “oceanic boundlessness” and “mystical-type experiences” have been shown to predict not only long-term increases in well-being (80, 85) and trait openness in non-clinical samples (59, 60, 89) but also positive clinical outcomes (5, 7, 11, 46).”
BackgroundConstructing drug effects: a history of set and setting
Hartogsohn, I. (2017) · Drug Science Policy and Law · doi:10.1177/2050324516683325 · Cited by 472 · cited 1×
“, a heightened susceptibility toward ongoing processes in the internal and external context [or “set” and “setting”; see (64, 65)].”
BackgroundEgo-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI).
Nour, M. M., Evans, L., Nutt, D., & Carhart-Harris, R. L. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00269 · Cited by 470 · cited 1×
“, a transiently compromised experience of self that is characterized by a sense of unity with one's surroundings (86).”
BackgroundAvoidance and depression: the construction of the Cognitive–Behavioral Avoidance Scale
Ottenbreit, N. D., & Dobson, K. S. (2004) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(03)00140-2 · Cited by 457 · cited 1×
“, (57, 81)] and related phenomena such as avoidant coping [e.”
BackgroundThe brief experiential avoidance questionnaire: Development and initial validation
Gámez, W., Chmielewski, M., Kotov, R., Ruggero, C., Suzuki, N., & Watson, D. (2014) · Psychological Assessment · doi:10.1037/a0034473 · Cited by 450 · cited 1×
“, (57, 81)] and related phenomena such as avoidant coping [e.”
BackgroundMindfulness Meditation and Psychopathology
Wielgosz, J., Goldberg, S. B., Kral, T. R. A., Dunne, J. D., & Davidson, R. J. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093423 · Cited by 435 · cited 1×
“The similarity between mindfulness and other exposure treatments is reflected in that regular mindfulness exercise structurally and functionally affects the same network of brain regions that is also assumed to support fear extinction (36, 37), suggesting that this type of “internal” exposure can reduce avoidance via…”
BackgroundPredicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · cited 4×
“The common phenomenon that a challenging psychedelic experience is suddenly resolved in a moment of breakthrough (54) could be explained as the result of such rapid shaping-like processes.”
BackgroundResultInfluentialPreller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402
Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375 · cited 1×
“In line with this idea, a recent survey study (91) found that the impact of acute mysticaltype effects on decreases in depression and anxiety after naturalistic psychedelic use was entirely mediated by increases in psychological flexibility (a construct that is closely related to acceptance).”
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J.-M. S., Johnson, M. W., & Griffiths, R. R. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116678781 · Cited by 366 · cited 1×
“These challenging experiences(1) (42, 52, 53) are often characterized by extreme fear or panic, and can involve frightening imagery, unsettling body sensations, and the apprehension of immediate threat.”
BackgroundAgin-Liebes, G. I., Malone, T., Yalch, M. M., Mennenga, S. E., Ponté, K. L., Guss, J., Bossis, A. P., Grigsby, J., Fischer, S., & Ross, S. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119897615 · Cited by 360
Acceptance and commitment therapy: altering the verbal support for experiential avoidance
Hayes, S. C., & Wilson, K. G. (1994) · The Behavior Analyst · doi:10.1007/bf03392677 · Cited by 354
Psychiatry & the psychedelic drugs. Past, present & future
Rucker, J. J. H., Iliff, J., & Nutt, D. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.040 · Cited by 343 · cited 1×
“In line with this, pre-prohibition clinical studies, which tested psychedelics for mental disorders across the board, found positive results mostly in (then so-called) “psychoneurotic” disorders (105).”
ResultExploring the roles of approach and avoidance in depression: An integrative model
Trew, J. L. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.07.007 · Cited by 316
Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., Guss, J., Bossis, A., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817706884 · Cited by 311 · cited 4×
“Such reports of exceptional openness to previously “hidden” or “suppressed” feelings during dosing sessions (13, 48, 49) suggest that conditioned acceptance may yield unique opportunities for exposure to private events that are otherwise avoided.”
BackgroundResultInfluentialLSD‐induced entropic brain activity predicts subsequent personality change
Lebedev, A. V., Kaelen, M., Lövdén, M., Nilsson, J., Feilding, A., Nutt, D. J., & Carhart‐Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23234 · Cited by 303
Self unbound: ego dissolution in psychedelic experience
Letheby, C., & Gerrans, P. (2017) · Neuroscience of Consciousness · doi:10.1093/nc/nix016 · Cited by 293 · cited 1×
“From a predictive processing perspective, ego dissolution can be explained in terms of a transient disruption of self-related highlevel beliefs (14, 87, 88).”
BackgroundThe paradoxical psychological effects of lysergic acid diethylamide LSD
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., & Nutt, D. J. (2016) · Psychological Medicine · doi:10.1017/s0033291715002901 · Cited by 293 · cited 1×
“Blissful ego-dissolution and related phenomena such as “oceanic boundlessness” and “mystical-type experiences” have been shown to predict not only long-term increases in well-being (80, 85) and trait openness in non-clinical samples (59, 60, 89) but also positive clinical outcomes (5, 7, 11, 46).”
BackgroundEffects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12904 · Cited by 267
Psychedelics and connectedness
Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4701-y · Cited by 265
Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.04.009 · Cited by 248
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230
Psychedelics, personality and political perspectives.
Nour, M. M., Evans, L., & Carhart-Harris, R. L. (2017) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2017.1312643 · Cited by 226
Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209
Millière, R. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00245 · Cited by 206 · cited 1×
“From a predictive processing perspective, ego dissolution can be explained in terms of a transient disruption of self-related highlevel beliefs (14, 87, 88).”
BackgroundSwift, T. C., Belser, A. B., Agin-Liebes, G., Devenot, N., Terrana, S., Friedman, H. L., Guss, J., Bossis, A. P., & Ross, S. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817715966 · Cited by 195 · cited 1×
“Whereas qualitative analyses of patient interviews (13, 48, 49, 51) are compatible with this view, quantitative studies are needed to test and further develop the proposed model.”
ResultThe Beliefs about Emotions Scale: Validity, reliability and sensitivity to change
Rimes, K. A., & Chalder, T. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.09.014 · Cited by 188 · cited 1×
“, (82)], thought suppression (83), and beliefs about the unacceptability of emotions (84).”
BackgroundCarvalho, J. P., & Hopko, D. R. (2011) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/j.jbtep.2010.10.001 · Cited by 176
Sloshower, J., Guss, J., Krause, R., Wallace, R. M., Williams, M. T., Reed, S., & Skinta, M. D. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.002 · Cited by 171
Active Inference, Attention, and Motor Preparation
Brown, H., Friston, K., & Bestmann, S. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00218 · Cited by 165 · cited 1×
“, acting on the environment to reduce uncertainty; (67)].”
BackgroundThe psychedelic mystical experience in the human encounter with death
Pahnke, W. N. (1969) · Harvard Theological Review · doi:10.1017/s0017816000027577 · Cited by 147
A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy
Sessa, B., Higbed, L., & Nutt, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00138 · Cited by 141 · cited 6×
“This encompasses many of the most prevalent mental disorders, including some that are already in the focus of psychedelic research (e.g., depression and addiction) and others for which modern clinical trials have not yet been conducted, such as panic disorder, posttraumatic stress disorder (PTSD), or psychosomatic dis…”
BackgroundMethodInfluentialSoler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00224 · Cited by 102
Bahji, A., Forsyth, A., Groll, D., & Hawken, E. R. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109735 · Cited by 88
Zeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67
Research works printed but not linked: 42
- Bullis, 2019, What is an emotional disorder? A transdiagnostic mechanistic definition with implications for assessment, treatment, and prevention, Clin Psychol: Sci Pract, 26, 10.1111/cpsp.12278 · DOI · Paper page
- Brockmeyer, 2015, Differentiating early-onset chronic depression from episodic depression in terms of cognitive-behavioral and emotional avoidance, J Affect Disord, 175, 10.1016/j.jad.2015.01.045 · DOI
- Ottenbreit, 2008, Avoidance, 10.1016/B978-0-08-045078-0.00020-4 · DOI
- Linehan, 1994, Acceptance and change: the central dialectic in psychotherapy, 73
- Segal, 2002, Mindfulness-based cognitive therapy for depression: A new approach to preventing relapse
- Rief, 2015, Expectancies as core features of mental disorders, Curr Opin In Psychiatry, 28, 10.1097/YCO.0000000000000184 · DOI · Paper page
- Beck, 2011, Cognitive behavior therapy: Basics and beyond
- Safran, 1990, Interpersonal process in cognitive therapy
- Moore, 2003, Cognitive therapy for chronic and persistent depression, 10.1002/9780470713495 · DOI · Paper page
- Hayes, 2004, Mindfulness and acceptance: Expanding the cognitive-behavioral tradition
- Grosse Holtforth, 2008, Avoidance motivation in psychological problems and psychotherapy, Psychother Res, 18, 10.1080/10503300701765849 · DOI · Paper page
- Clark, 2011, Cognitive therapy of anxiety disorders: Science and practice
- Slagle, 2007, The utility of motivational interviewing as an adjunct to exposure therapy in the treatment of anxiety disorders, Prof Psychol: Res Pract, 38, 10.1037/0735-7028.38.4.329 · DOI
- Garcia-Romeu, 2018, Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions, Int Rev Psychiatry, 30, 291, 10.1080/09540261.2018.1486289 · DOI · Paper page
- Swanson, 2018, Unifying theories of psychedelic drug effects, Front Pharmacol, 9, 1, 10.3389/fphar.2018.00172 · DOI · Paper page
- Roseman, 2018, Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression, Front Pharmacol, 8, 10.3389/fphar.2017.00974 · DOI · Paper page
- Majić, 2014, Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences, J Psychopharmacol, 29, 10.1177/0269881114568040 · DOI · Paper page
- Gasser, 2015, LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects, J Psychopharmacol, 29, 57, 10.1177/0269881114555249 · DOI · Paper page
- Nielson, 2018, The psychedelic debriefing in alcohol dependence treatment: illustrating key change phenomena through qualitative content analysis of clinical sessions, Front In Pharmacol, 9, 1, 10.3389/fphar.2018.00132 · DOI · Paper page
- Carbonaro, 2016, Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences, J Psychopharmacol, 30, 10.1177/0269881116662634 · DOI · Paper page
- Mertens, 2020, Therapeutic mechanisms of psychedelic drugs: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
- Pink-Hashkes, 2017, Perception is in the details: a predictive coding account of the psychedelic phenomenon
- Skinner, 1953, Science and human behavior
- Kaelen, 2018, The hidden therapist: evidence for a central role of music in psychedelic therapy, Psychopharmacology, 235, 10.1007/s00213-017-4820-5 · DOI · Paper page
- Barrett, 2018, Psychedelics and music: neuroscience and therapeutic implications, Int Rev Psychiatry, 1, 10.1080/09540261.2018.1484342 · DOI · Paper page
- Kaelen, 2016, LSD modulates music-induced imagery via changes in parahippocampal connectivity, Eur Neuropsychopharmacol, 26, 10.1016/j.euroneuro.2016.03.018 · DOI
- Kaelen, 2015, LSD enhances the emotional response to music, Psychopharmacology, 232, 10.1007/s00213-015-4014-y · DOI
- Kaelen, 2017, Effects of LSD on music-evoked brain activity, 10.1101/153031 · DOI
- Finset, 2002, The brief approach/avoidance coping questionnaire: development and validation, Psychol Health Med, 7, 75, 10.1080/13548500120101577 · DOI
- Russ, 2019, Replication and extension of a model predicting response to psilocybin, Psychopharmacology, 236, 10.1007/s00213-019-05279-z · DOI
- Hendricks, 2018, Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy, Int Rev Psychiatry, 1, 10.1080/09540261.2018.1474185 · DOI · Paper page
- Hayes, 2019, The centrality of sense of self in psychological flexibility processes: what the neurobiological and psychological correlates of psychedelics suggest, J Context Behav Sci, 15, 30, 10.1016/j.jcbs.2019.11.005 · DOI
- Luoma, 2019, Toward a contextual psychedelic-assisted therapy: perspectives from acceptance and commitment therapy and contextual behavioral science, J Context Behav Sci, 14, 10.1016/j.jcbs.2019.10.003 · DOI · Paper page
- Walsh, 2018, Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy, Int Rev Psychiatry, 30, 10.1080/09540261.2018.1474088 · DOI · Paper page
- Watts, 2020, The use of the psychological flexibility model to support psychedelic assisted therapy, J Contextual Behav Sci, 15, 92, 10.1016/j.jcbs.2019.12.004 · DOI · Paper page
- Collard, 2019, ACT vs CBT: an exercise in idiosyncratic language, Int J Cogn Ther, 12, 10.1007/s41811-019-00043-9 · DOI
- Ellis, 2005, Can Rational-Emotive Behavior Therapy (REBT) and Acceptance and Commitment Therapy (ACT) resolve their differences and be integrated, J Rational - Emotive Cogn - Behav Ther, 23, 10.1007/s10942-005-0008-8 · DOI
- Noorani, 2018, Psychedelic therapy for smoking cessation: qualitative analysis of participant accounts, J Psychopharmacol, 32, 10.1177/0269881118780612 · DOI · Paper page
- Bogenschutz, 2017, Development of a psychotherapeutic model for psilocybin-assisted treatment of alcoholism, J Human Psychol, 57, 389, 10.1177/0022167816673493 · DOI · Paper page
- Nielson, 2018, The influence of therapists' first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training, J Psychedelic Stud, 2, 64, 10.1556/2054.2018.009 · DOI · Paper page
- Feduccia, 2018, MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms, Prog Neuropsychopharmacol Biol Psychiatry, 84, 10.1016/j.pnpbp.2018.03.003 · DOI · Paper page
- Nielson, 2014, Ayahuasca as a candidate therapy for PTSD, 41, 10.1007/978-3-642-40426-9_3 · DOI
Cited by
Aday, J. S., Davis, A. K., Mitzkovitz, C. M., Bloesch, E. K., & Davoli, C. C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00014 · Cited by 224
Psychedelics and psychotherapy: Cognitive-behavioral approaches as default
Yaden, D. B., Earp, D., Graziosi, M., Friedman-Wheeler, D., Luoma, J. B., & Johnson, M. W. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.873279 · Cited by 110
Zeifman, R. J., Wagner, A. C., Watts, R., Kettner, H., Mertens, L. J., & Carhart-Harris, R. L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00782 · Cited by 106
“Therefore, we suggest that integrating psychedelics and psychotherapeutic interventions that specifically target experiential avoidance may help to enhance and prolong (93) the effectiveness of psychedelic therapy [for discussions, see (87, 94, 95)].”
BackgroundSelf-citationDoes Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661233 · Cited by 96
Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
Spriggs, M. J., Douglass, H. M., Park, R. J., Read, T., Danby, J. L., de Magalhães, F. J. C., Alderton, K. L., Williams, T. M., Blemings, A., Lafrance, A., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.735523 · Cited by 75
Metadata
- Authors
- Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2020-02-21
- Volume
- 11
- Pages
- 5-5
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W3007835064
- Cited by
- 194
- References
- 68
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.